Aclarion inc

US StockHealth Care

ACON AI Analysis Overview

Keys for Bullish View

  • Value≥4
  • Dividend≥2

Analysis Conclusion

With insufficient quarterly financial data released by the company, we're unable to provide a rating.

ACON Current Performance

-25.82%

Aclarion inc

0.68%

Avg of Sector

0.03%

S&P500

Top 10 High Relevance to ACON

  • SNOA Sonoma pharmaceuticals inc
    Value 2Trend 2Swing Trading 4Whale Interest 1Dividend 1
    See more

ACON Profile

Aclarion, Inc. is a healthcare technology company that employs magnetic resonance spectroscopy (MRS) and, and a biomarker to optimize clinical treatments. The Company's signal processing software and expert system transform raw spectral MRS data into clear metabolic biomarkers to help physicians determine between painful and nonpainful discs of the lumbar spine. The Company is using augmented intelligence in a post-processing algorithm to analyze and quantifies the biomarker data, generating ratio metrics for each lumbar disc that are individualized to a normative data set. The Company's technology is focused on the care of patients suffering from chronic low back pain.

Price of ACON